PGT-A Testing Class Action Lawsuits
Constable Law, along with co-counsel Justice Law Collaborative and Berger Montague, filed class action lawsuits against multiple genetic testing companies for misleading consumers about the benefits and capabilities of the genetic test preimplantation genetic testing for aneuploidy, or PGT-A.
The lawsuits are filed against the following genetic testing companies: CooperGenomics, Inc./CooperSurgical, Inc.; Reproductive Genetic Innovations, LLC.; Progenesis, Inc.; Natera, Inc.; FPG Labs, LLC d/b/a Ovation Fertility; and Igenomix USA/Vitrolife.
They include the following cases: Weinberg, et al. v. CooperGenomics, Inc., et al., No. 2:24-cv-09505-MEF-LDW (D.N.J.), filed in the District of New Jersey; Donamaria v. Reproductive Genetic Innovations, LLC., No. 1:24-cv-09535 (N.D. Ill.), filed in the Northern District of Illinois; Cruz, et al. v. Progenesis, Inc., No. 3:24-cv-01789-JES-AHG (S.D. Cal.), filed in the Southern District of California; and Petersen, et al. v. Natera, Inc., No. 3:24-cv-07062 (N.D. Cal.), filed in the Northern District of California; Klosowski, et al. v. FPG Labs, LLC d/b/a Ovation Fertility, et al., No. 1:24-cv-01210 (Del.), and M.M., et al. v. Igenomix USA, Inc., et al., No. 1:25-cv-21008 (S.D.Fl.)
The lawsuits allege consumer fraud, breach of warranty, and related claims arising out of the defendants’ advertising and sale of PGT-A, a test which typically costs thousands of dollars not covered by insurance. Consumers are told, the complaints allege, that PGT-A increases the success of IVF and the chance of a healthy IVF pregnancy, decreases the chance of miscarriage, and reduces the time to pregnancy by screening the chromosomal makeup of fertilized human embryos for abnormalities. However, scientific studies have shown that PGT-A is inaccurate and unproven. Despite a lack of credible and reliable data proving the test’s capabilities and benefits, the use of PGT-A has increased significantly, generating hundreds of millions in revenue for genetic testing companies.
The plaintiffs seek to recover their out-of-pocket costs spent on PGT-A as well as statutory and other damages resulting from the defendants’ allegedly false and misleading promotion of PGT-A.
If you have any questions about the lawsuits, please reach out to allison@constable-law.com or fill out the form below:
Posts and Articles about the PGT-A Class Action Lawsuits
Read the Times article.
Read the Voice article.
Read the Reproductive Times article.
Read the Truthdig article.
Read the Bloomberg Law article.
Read the Progress Educational Trust article.
Read the Inside Reproductive Health article.
Read the Center for Human Reproduction blog post.
Read the opinion piece in Ova.
Luminary Genetics (formerly known as NextGen) - On June 26, 2025, a class action lawsuit was filed against Luminary Genetics, formerly known as NextGen Genetics. The lawsuit includes claims of fraud, false advertising, breach of warranty, and other consumer protection violations regarding Luminary’s sale of its PGT-A testing. Plaintiffs are seeking damages and restitution for patients who paid for PGT-A testing marketed by Santa Clara, California-based Luminary Genetics.
For more information, please see the lawsuit or you may reach out to p allison@constable-law.com or fill out the form below.